Why Tobira Therapeutics Inc Was an Overnight Octuple

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 20 September, 2016 by The TZ Newswire Staff

Why Tobira Therapeutics Inc Was an Overnight Octuple

Liver

Image source: Getty Images.

Tobira Therapeutics (NASDAQ: TBRA) is up more than 700% today after Allergan (NYSE: AGN) announced that the big biotech was purchasing its smaller brethren.

See also
- Next Article Coming up: Adam and Eamonn talk Fed and BOJ
- Previous Article LA is experiencing the rise of the modern spec home
Editorial Calender

September 2016

M T W T F S S

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30

« Aug Oct »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 20 September, 2016 by The TZ Newswire Staff

Why Tobira Therapeutics Inc Was an Overnight Octuple

See also

Editorial Calender

Recent Tags